Company intelligence / Profile preview
Regenerative Medical Solutions
Madison, Wisconsin, United Statesregenmedsolutions.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
RMS has developed patented methods for differentiating human induced pluripotent stem cells into insulin-producing islet-like clusters. These are being evaluated as both research tools and potential curative therapies for diabetes. The company has had successful preclinical studies and a recent positive FDA meeting but does not yet have published clinical trial results
- Therapeutic areas
- Endocrinology
- Modalities
- Induced pluripotent stem cell derived therapyCell therapyBiologic (as a broader category)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with University of Wisconsin-Madison researchers
Beyond the preview
Go deeper on Regenerative Medical Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regenerative Medical Solutions.